Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Voyager Therapeutics Inc.

    NASDAQ: VYGR · Real-Time Price · USD
    3.29
    -0.31 (-8.61%)
    At close: Jun 13, 2025, 3:59 PM
    3.48
    5.78%
    After-hours: Jun 13, 2025, 04:36 PM EDT

    Voyager Therapeutics Statistics

    Share Statistics

    Voyager Therapeutics has 55.34M shares outstanding. The number of shares has increased by 1.5% in one year.

    Shares Outstanding

    n/a
    		 55.34M

    Shares Change (YoY)

    n/a
    		 1.5%

    Shares Change (QoQ)

    n/a
    		 1.06%

    Owned by Institutions (%)

    n/a
    		 59.77%

    Shares Floating

    n/a
    		 45M

    Failed to Deliver (FTD) Shares

    n/a
    		 530

    FTD / Avg. Volume

    n/a
    		 0.11%

    Short Selling Information

    The latest short interest is 3.2M, so 5.78% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 3.2M

    Short % of Shares Out

    n/a
    		 5.78%

    Short % of Float

    n/a
    		 6.9%

    Short Ratio (days to cover)

    n/a
    		 9.06

    Valuation Ratios

    The PE ratio is -5.03 and the forward PE ratio is -2.15. Voyager Therapeutics's PEG ratio is 0.04.

    PE Ratio

    n/a
    		 -5.03

    Forward PE

    n/a
    		 -2.15

    PS Ratio

    n/a
    		 4.09

    Forward PS

    n/a
    		 2.4

    PB Ratio

    n/a
    		 1.09

    P/FCF Ratio

    n/a
    		 -17.36

    PEG Ratio

    n/a
    		 0.04
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Voyager Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 5.56, with a Debt / Equity ratio of 0.15.

    Current Ratio

    n/a
    		 5.56

    Quick Ratio

    n/a
    		 5.56

    Debt / Equity

    n/a
    		 0.15

    Debt / EBITDA

    n/a
    		 -0.56

    Debt / FCF

    n/a
    		 -2.32

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $465,122.09

    Profits Per Employee

    n/a
    		 $-377,918.6

    Employee Count

    n/a
    		 172

    Asset Turnover

    n/a
    		 0.2

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 665K

    Effective Tax Rate

    n/a
    		 -1.03%

    Stock Price Statistics

    The stock price has increased by -61.34% in the last 52 weeks. The beta is 0.82, so Voyager Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.82

    52-Week Price Change

    n/a
    		 -61.34%

    50-Day Moving Average

    n/a
    		 3.26

    200-Day Moving Average

    n/a
    		 5.06

    Relative Strength Index (RSI)

    n/a
    		 50.26

    Average Volume (20 Days)

    n/a
    		 486,969

    Income Statement

    In the last 12 months, Voyager Therapeutics had revenue of 80M and earned -65M in profits. Earnings per share was -1.13.

    Revenue

    n/a
    		 80M

    Gross Profit

    n/a
    		 80M

    Operating Income

    n/a
    		 -83.29M

    Net Income

    n/a
    		 -65M

    EBITDA

    n/a
    		 -78.56M

    EBIT

    n/a
    		 -83.29M

    Earnings Per Share (EPS)

    n/a
    		 -1.13
    Full Income Statement

    Balance Sheet

    The company has 71.37M in cash and 43.73M in debt, giving a net cash position of 27.64M.

    Cash & Cash Equivalents

    n/a
    		 71.37M

    Total Debt

    n/a
    		 43.73M

    Net Cash

    n/a
    		 27.64M

    Retained Earnings

    n/a
    		 -326.18M

    Total Assets

    n/a
    		 353.24M

    Working Capital

    n/a
    		 204.99M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -15.31M and capital expenditures -3.52M, giving a free cash flow of -18.83M.

    Operating Cash Flow

    n/a
    		 -15.31M

    Capital Expenditures

    n/a
    		 -3.52M

    Free Cash Flow

    n/a
    		 -18.83M

    FCF Per Share

    n/a
    		 -0.33
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -104.11% and -81.25%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -104.11%

    Pretax Margin

    n/a
    		 -80.42%

    Profit Margin

    n/a
    		 -81.25%

    EBITDA Margin

    n/a
    		 -98.19%

    EBIT Margin

    n/a
    		 -104.11%

    FCF Margin

    n/a
    		 -23.54%

    Dividends & Yields

    VYGR does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for VYGR is $12, which is 264.7% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $12

    Price Target Difference

    n/a
    		 264.7%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 7
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -0.11

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist